The HCT/P Modernization Act of 2025 aims to modernize the regulation of human cell and tissue products.
The HCT/P Modernization Act of 2025 directs the Secretary of Health and Human Services to streamline regulatory oversight of human cell and tissue products. The Secretary must publish educational materials about the Tissue Reference Group on the FDA website and conduct workshops for stakeholders. The Act also mandates the establishment of a public docket for comments on regulatory approaches and requires a report to Congress with recommendations on human cell and tissue product regulation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.